Kalyanaka Ghrita: No Human Evidence, Only Tradition
TL;DR
Kalyanaka ghrita is a classical medicated ghee used for Unmada, the Ayurvedic category of mental disorders, as well as epilepsy and hysteria. It has never been tested as a standalone medicine in any human trial. The only study, a 1992 trial in 36 schizophrenia patients, used it as one small part of a complex multi-treatment package, with unusable psychological-outcome data.
What it is
Kalyanaka ghrita is a polyherbal medicated ghee (ghrita) prepared by processing ghee with herbs such as Amalaki, Haritaki, Bibhitaki, Haridra, Daruharidra, Vishala, and others. It is traditionally given orally, sometimes as Snehapana (therapeutic oleation) before purgation procedures.
A 2019 review by a CCRAS research officer analyzed the formulation's 28 ingredients: 15 are Tikta (bitter) in taste, 22 are Laghu (light), and 19 are Ushna (heating) in potency. 18 have Katu (pungent) post-digestive effect, and 12 ingredients pacify Kapha and Pitta. The review presents it as a psychiatric formulation, possibly best suited to Kapha-type Unmada (mental derangement).
Traditional use
Traditionally, Kalyanaka ghrita is the signature ghrita for Unmada (mental disorders), Apasmara (epilepsy), and Hysteria-type conditions, and classical texts list it among the formulas a physician should consider for severe mental illness. Modern Ayurvedic review articles analyze its ingredient profile as predominantly Kapha-opposing, suggesting a fit for Kaphaja-type unmada.
What modern research says
Schizophrenia package trial (Kalyanaka ghrita as one component only)
The best-known clinical reference is the Ramu 1992 trial reviewed in a 2007 Cochrane review on Ayurvedic medicine for schizophrenia. Thirty-six hospital patients (schizophrenia by ICD-9 and unmada by Charaka's definition) were allocated to either a multi-part Ayurvedic treatment package or chlorpromazine for 28 days. Kalyanaka ghrita appeared only as Snehapana for 3–7 days in the Ayurvedic arm, alongside purgation, medicated oils, powders, herbal wines, and psychobehavioral therapy. The review rated the psychological-outcome data unusable and found the evidence overall insufficient to support Ayurvedic medicine over standard care. This trial says nothing about Kalyanaka ghrita as a medicine on its own.
What the evidence does not support (yet)
There is no randomized, controlled, or even observational study of Kalyanaka ghrita as a standalone treatment for any condition. No human trial exists for epilepsy, OCD, anxiety, or any other claimed use. Ingredient-level animal pharmacology cannot stand in for formulation-level evidence.
Safety & contraindications
There is no modern safety profile for Kalyanaka ghrita: no dose-finding study, no adverse-event data, no data for pregnancy or breastfeeding. The conditions it is used for are serious medical conditions: schizophrenia, bipolar disorder, severe depression, and epilepsy. Each requires professional diagnosis and treatment. Self-medicating a psychotic or seizure disorder with an untested herbal ghee can lead to harm through delayed effective care. Anyone with psychiatric or seizure symptoms should see a doctor; Ayurvedic care, if wanted, should run alongside medical supervision, never instead of it.
FAQs
What is Kalyanaka ghrita?
It is a classical Ayurvedic medicated ghee made by processing ghee with herbs, traditionally used for mental disorders (Unmada) and epilepsy.
Does it work for schizophrenia or epilepsy?
Unknown. It has never been tested alone in humans. A 1992 trial that included it in a multi-part Ayurvedic package produced no usable efficacy data, per Cochrane.
Can it replace psychiatric medication?
No. Psychotic and seizure disorders need professional medical treatment. Stopping prescribed medication for an untested herbal preparation is dangerous.
Why is this article so short?
Because the entire clinical evidence base is one old trial in which the ghrita was a minor component of a treatment package. Padding would mislead.
What is the recommended dose?
This article omits dosage because no pharmacopoeial or clinical-trial citation supports one.
Is it safe in pregnancy?
Unknown, with no data whatsoever. Psychiatric and neurological conditions in pregnancy require specialist care.
Sources
- A 2007 Cochrane review on Ayurvedic medicine for schizophrenia, which reviewed the Ramu 1992 trial (n = 36) that used Kalyanaka ghrita only as part of a multi-part Ayurvedic treatment package, and found the psychological-outcome data unusable: Ayurvedic medicine for schizophrenia (Cochrane)
- A 2019 peer-reviewed review analyzing the probable mode of action of Kalyanaka ghrita in unmada from its ingredients' Ayurvedic pharmacological properties: Probable mode of action of Kalyanaka ghrita in unmada based on analysis of Rasa Panchaka
Related herbs
Disclaimer
This article is for education only and is not medical advice. Kalyanaka ghrita has no standalone human efficacy evidence and no established safety profile. Never self-treat psychosis, depression, or epilepsy, and never stop prescribed medication without medical guidance.